Allogene Therapeutics Announces Participation in Four Upcoming Virtual Investor Conferences

NEXT STORY
Agenus Announces New Responses for AGEN1181
PREV STORY
electroCore Announces Publication of Study on Non-Invasive Vagus Nerve Stimulation (nVNS) to Reduce Ileus After Major Colorectal Surgery
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Relypsa Announces FDA Approval of Supplemental New Drug Application to Enable the Usage of Veltassa® (patiromer) With or Without Food

author_avatar
NASDAQ Market News

LHC Group promotes Joshua Proffitt to President and welcomes Robert Williams as new Chief Financial Officer

author_avatar
NASDAQ Market News

NANOBIOTIX presents first promising data from Phase I/II Liver Cancers trial of NBTXR3 at the American Society Of Clinical Oncology Gastrointestinal Annual Meeting

 NANOBIOTIX PRESENTS FIRST PROMISING DATA FROM PHASE I/II LIVER CANCERS TRIAL OF NBTXR3 AT THE ...

author_avatar
NASDAQ Market News